Robotic-assisted surgery is establishing a new benchmark in surgical precision and patient care. The robotic surgery market is projected to grow from USD 8.28 billion in 2025 to USD 16.40 billion by 2032, with a CAGR of 10.25 % during the forecast period. An integration of artificial intelligence (AI) and machine learning into next-generation robotic platforms is accelerating Robotic Surgery adoption. Despite its strong potential, the adoption of surgical robotics in hospitals continues to face several key challenges. High capital costs remain a major barrier, as a single robotic surgical system typically costs USD 1.5–2.0 million, in addition to ongoing maintenance and training expenses.
Robotic Surgery Market Key Highlights
North America led with 44.60 % Robotic Surgery market share in 2025, driven by high surgical volumes, early adoption of robotic platforms, and strong presence of market leaders such as Intuitive Surgical and Medtronic.
Robotic-assisted procedures are becoming the standard of care in select indications, with robotic prostatectomy accounting for over 80% of prostate cancer surgeries in developed markets.
Hospitals accounted for 45.11% of the market in 2025 because of their advanced infrastructure, higher surgical volumes, and capital investment capacity.
Industry leaders such as Intuitive Surgical, Medtronic, and CMR Surgical dominate the market, with Intuitive Surgical alone accounting for over 70% of the global surgical robot installed base, driven by continuous platform upgrades and ecosystem expansion.
Chart Loading...
Chart ID: 696f4bfde9f9736ca7b8f561
Global Robotic Surgery Market Size, by Product
Systems dominated the global robotic surgery market in 2025, accounting for 57.5% of total Robotic Surgery market share, primarily because of the high capital cost of surgical robotic platforms and navigation systems. An ongoing installation of next-generation robotic platforms, technological upgrades, and strong demand across high-volume procedures such as urology, gynecology, and general surgery are expected to boost the demand for Robotic Surgery Systems during the forecast period.
Software & Services held a smaller share at 15.8%, which are gaining importance because of rising adoption of AI-enabled software, system maintenance contracts, and surgeon training services.
Chart Loading...
Chart ID: 696f4cd3e9f9736ca7b8f57f
Robotic Surgery Market Segmentation Covered
Segmentation Type | Segmentation |
By Product |
|
By Deployment Model |
|
By Application |
|
End Use |
|
Robotic Surgery Market Regional Analysis
North America represents the largest share of the global robotic surgery market, accounting for 3.19 Bn. total revenue, reflecting strong market maturity. The market growth is driven by advanced surgical infrastructure, favourable reimbursement, high surgeon training penetration, and early adoption of AI-enabled robotic platforms.
In Canada, more than 40 hospitals have adopted robotic surgical systems, reflecting steady progress. Despite a steady adoption growth, high system costs and training requirements are expected to limit Robotic Surgery market revenue across smaller and budget-constrained healthcare facilities.
Robotic surgery adoption across Europe is gaining momentum, with Germany, France, and the U.K. accounting for over 60% of installed robotic surgical systems in the region.
Asia-Pacific is emerging as high-growth regions, supported by rising government healthcare investments, expanding hospital infrastructure, and increasing demand for precision-based surgical procedures.
Robotic Surgery Market Competitive Landscape & Strategic Outlook
The Robotic Surgery market growth is witnessing strong momentum driven by increased strategic partnerships, rapid technological advancements, and growing AI integration. In October 2025, Panda Surgical raised up USD 1.34 million to advance its handheld neurosurgical robot, reflecting increased investor interest in specialized robotic solutions. Intuitive Surgical continues to dominate the global surgical robotics market, holding nearly 38% share of total Robotic Surgery market share in 2025, supported by the widespread adoption of its da Vinci surgical system, a large installed base, comprehensive surgeon training programs, and continuous technological innovation
Competitive Benchmarking of Leading Companies in the Global Robotic Surgery Market
Company | Approx. Market Share (2024–25) | Key Products / Strengths | Focus Areas |
Intuitive Surgical | ~35–38% | da Vinci RAS platforms (Xi, X, SP), Ion endoluminal system | Minimally invasive surgery, installed base expansion, AI-enabled upgrades |
Medtronic | ~20–24% | Hugo RAS, Mazor X Stealth | Soft tissue, spine robotics, global expansion |
Stryker | ~15% | Mako orthopedic robotics | Joint replacement precision, hospital networks |
Johnson & Johnson (Ethicon / Verb Surgical) | ~10% | Ottava, Monarch (via Auris Health) | Robotics across soft tissue and endoluminal procedures |
Zimmer Biomet | ~5% | ROSA orthopedic robot; recent acquisitions to expand robotics | Orthopedic and semi-autonomous systems |
Smith+Nephew | ~5% | CORI Surgical System | Orthopedic robotics and digital surgery |
Siemens Healthineers | ~4% | Imaging-integrated robotic/navigation systems | Imaging + navigation for precision procedures |
Philips Healthcare | <3% (approx.) | Image-guided robotic systems | Advanced imaging + procedural guidance |
KARL STORZ (with Asensus) | ~3% (Asensus) | Robotic-assisted endoscopy (Senhance + endoscopy robotics) | Endoscopic robotics & integration |
Asensus Surgical | ~3% | Senhance digital laparoscopy | AI-enhanced laparoscopic robotics |